98 related articles for article (PubMed ID: 2899298)
1. Successful treatment of ophthalmoplegia in acromegaly with the somatostatin analogue SMS 201-995.
van Liessum PA; Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
Neth J Med; 1988 Jun; 32(5-6):289-92. PubMed ID: 2899298
[No Abstract] [Full Text] [Related]
2. Effect of the somatostatin analogue SMS 201-995 on faecal fat excretion in acromegaly.
McGregor AR; Troughton WD; Donald RA; Espiner EA
Horm Metab Res; 1990 Jan; 22(1):55-6. PubMed ID: 1968417
[No Abstract] [Full Text] [Related]
3. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
N Engl J Med; 1986 May; 314(21):1390-2. PubMed ID: 2871490
[No Abstract] [Full Text] [Related]
4. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
5. [100 years of acromegaly: general lessons about a rare disease].
Lamberts SW
Ned Tijdschr Geneeskd; 1986 May; 130(20):902-4. PubMed ID: 2873513
[No Abstract] [Full Text] [Related]
6. [Analgesic effect of a somatostatin analog, SMS 201-995, on headache associated with tumor of the hypophysis].
Webb SM; Cabezas R; Montañés R; de Leiva A
Med Clin (Barc); 1989 Oct; 93(13):501-2. PubMed ID: 2622243
[TBL] [Abstract][Full Text] [Related]
7. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
Laczi F; Magony S; Julesz J
Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly.
Bloom SR
Am J Med; 1987 May; 82(5B):88-91. PubMed ID: 2884882
[TBL] [Abstract][Full Text] [Related]
9. Another case where bigger is not better.
Weber KT
Cardiovasc Res; 1997 Oct; 36(1):1-2. PubMed ID: 9415265
[No Abstract] [Full Text] [Related]
10. Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
Miranda R; Zárate A; Ruíz Velasco G
Arch Invest Med (Mex); 1988; 19(4):445-8. PubMed ID: 3245759
[No Abstract] [Full Text] [Related]
11. [Ophthalmoplegia in acromegaly].
Molocznik I; Guitelman A; Artese de Guirlanda R; Martinez Montes AE; Provenzani A
Prensa Med Argent; 1971 Oct; 58(32):1595-600. PubMed ID: 5167090
[No Abstract] [Full Text] [Related]
12. Pharmacological options in the treatment of acromegaly.
Ezzat S
Curr Opin Investig Drugs; 2005 Oct; 6(10):1023-7. PubMed ID: 16259223
[TBL] [Abstract][Full Text] [Related]
13. The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly.
Popovic V; Paunovic VR; Micic D; Nesovic M; Kendereski A; Djordjevic P; Manojlovic D; Micic J
Horm Metab Res; 1988 Apr; 20(4):250-1. PubMed ID: 2899539
[No Abstract] [Full Text] [Related]
14. The effects of somatostatin analogs on biochemical parameters in acromegaly.
Liuzzi A; Marzullo P
J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
[No Abstract] [Full Text] [Related]
15. Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenoma.
Candrina R
Recenti Prog Med; 1994 Jan; 85(1):13-9. PubMed ID: 8184174
[TBL] [Abstract][Full Text] [Related]
16. Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995.
Musolino NR; Marino Júnior R; Bronstein MD
Clin J Pain; 1990 Sep; 6(3):243-5. PubMed ID: 2135020
[TBL] [Abstract][Full Text] [Related]
17. Evidence for dopamine agonists in the treatment of acromegaly.
Jaquet P
J Endocrinol; 1997 Oct; 155 Suppl 1():S59-60. PubMed ID: 9389998
[No Abstract] [Full Text] [Related]
18. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly.
Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E
J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214
[No Abstract] [Full Text] [Related]
19. A comparison among the effectiveness of growth hormone suppression in active acromegaly of bromocriptine and long acting somatostatin analogue (SMS 201-995).
Popović V; Nesović M; Mićić D; Kendereski A; Djordjević P; Manojlović D; Mićić J
Exp Clin Endocrinol; 1990 Apr; 95(2):251-7. PubMed ID: 1973122
[TBL] [Abstract][Full Text] [Related]
20. Effective and lasting growth-hormone suppression in active acromegaly with oral administration of somatostatin analogue SMS 201-995.
Williams G; Ball JA; Burrin JM; Joplin GF; Bloom SR
Lancet; 1986 Oct; 2(8510):774-8. PubMed ID: 2876235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
